ics 205-930 has been researched along with ondansetron in 1 studies
*Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [MeSH]
*Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papke, RL; Porter Papke, JK; Rose, GM | 1 |
1 other study(ies) available for ics 205-930 and ondansetron
| Article | Year |
|---|---|
Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Female; Indoles; Nicotinic Agonists; Ondansetron; Oocytes; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Spiro Compounds; Structure-Activity Relationship; Tropisetron; Xenopus laevis | 2004 |